Prices delayed by at least 15 minutes | Print
Genincode PLC (GENI)
ORD 1POpen
1.40p
Previous close
1.40p
Trade high
1.55p
Volume
1,796,795
Year high
9.76p
Year low
1.00p
Dividend yield
–
Market capitalisation
£4.37 mn
P/E ratio
–
ISIN
GB00BL97B504
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension,and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment the sale of kits and the provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain, and the United Kingdom.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 01/05/2025 | 04:36:34 | 1.5 | 250,000 | 3,750.00 |
| 01/05/2025 | 04:13:30 | 1.547 | 31,863 | 492.92 |
| 01/05/2025 | 03:15:29 | 1.55 | 5,366 | 83.17 |
| 01/05/2025 | 03:15:18 | 1.53 | 268,137 | 4,102.50 |
| 01/05/2025 | 02:57:25 | 1.4972 | 9,484 | 141.99 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.